TMDX — TransMedics Balance Sheet
0.000.00%
- $4.96bn
- $5.12bn
- $241.62m
- 37
- 6
- 100
- 45
Annual balance sheet for TransMedics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 28th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 80.7 | 126 | 92.5 | 201 | 395 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.56 | 6.86 | 5.93 | 27.6 | 63.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 100 | 147 | 119 | 252 | 511 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.79 | 4.75 | 15.7 | 24.4 | 180 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 105 | 152 | 135 | 277 | 706 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16.1 | 11.9 | 23.2 | 23.7 | 54.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 50.6 | 48.1 | 67 | 89.8 | 569 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 54.6 | 104 | 67.9 | 187 | 137 |
Total Liabilities & Shareholders' Equity | 105 | 152 | 135 | 277 | 706 |
Total Common Shares Outstanding |